A five-year-old boy with low-risk acute lymphoblastic leukemia survived 34 days of venovenous ECMO for severe pediatric ...
Some patients with severe COVID-19 who are treated with extracorporeal membrane oxygenation (ECMO) may experience significant lung recovery and return to normal lives with "meaningful" long-term ...
Patients with severe COVID-19 who require venovenous extracorporeal membrane oxygenation (VV-ECMO) support can, if carefully selected and managed, obtain “exceptional survival” approaching 87% at 1 ...
A notable proportion of patients receiving veno-venous extracorporeal membrane oxygenation (ECMO) for acute respiratory failure developed acute kidney injury (AKI), likely due to the greater severity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results